Accreditations
The Cell Therapy and Regenerative Medicine Program (CellReGen™) has established a comprehensive Quality Management System. Products developed and manufactured by CellReGen™ are registered and accredited by the following entities:
- American Association of Tissue Banks (AATB)
- Centers for Medicare and Medicaid Services - Clinical Laboratories Improvement Amendments (CLIA)
- College of American Pathologists (CAP)
- Food and Drug Administration (FDA)
- Foundation for the Accreditation of Cellular Therapy (FACT)
- Canada Health (CTO)
- Maryland Department of Health Tissue Bank Permit
- New York State Department of Health Tissue Bank License
- State of California Department of Public Health Tissue Bank License
![cap accreditation logo](public://media/images/2022/cap-accreditation_0.png)
![FACT accreditation](public://media/images/2022/Fact accreditation.png)
![FDA logo](public://media/images/2022/FDA accreditation_0.png)
![AATB logo](public://media/images/2022/AATB-with-tag2013_0.png)